章雄文 + 关注学者
  • 认领成果数 61
  • wos论文数 61
  • wos被引 1,469
  • wos篇均被引 24.08

全部成果分类

显示更多
导出 规范数据导出
  • 排序
  • 显示
2. Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities 代表性成果 SCOPUS SCIE PubMed

作者:Xi, JB;Fang, YF;Frett, B;Zhu, ML;Zhu, T;Kong, YN;Guan, FJ;Zhao, Y;Zhang, XW;Li, HY;Ma, ML;Hu, WH

通讯作者地址:Zhang, XW; Ma, ML; Hu, WH (reprint author), East China Normal Univ, Shanghai Engn Res Ctr, Mol Therapeut & New Drug Dev, Sch Chem & Mol Engn, 3663 North Zhongshan Rd, Shanghai 200062, Peoples R China.; Li, HY (reprint author), Univ Arkansas Med Sci, Coll Pharm, Dept Pharmaceut Sci, Little Rock, AR 72205 USA.

作者机构:[Xi, Jian-Bei; Fang, Yan-Fen; Zhu, Meng-Li; Zhu, Tong; Kong, Yan-Nan; Guan, Feng-Jie; Zhao, Yun; Zhang, Xiong-Wen; Ma, Ming-Liang; Hu, Wenhao] East Ch 更多

来源:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2017,126,1083-1106

收录类别:SCOPUS;SCIE;PubMed

当年影响因子:4.519

WOS被引:1

Scopus被引:2

资源类型:外文期刊论文

3. Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity 代表性成果 SCOPUS SCIE PubMed

作者:Fang, YF;Kong, YN;Xi, JB;Zhu, ML;Zhu, T;Jiang, TT;Hu, WH;Ma, ML;Zhang, XW

通讯作者地址:Ma, ML; Zhang, XW (reprint author), East China Normal Univ, Coll Chem & Mol Engn, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Shanghai, Peoples R China.

作者机构:[Fang, Yanfen; Kong, Yannan; Xi, Jianbei; Zhu, Mengli; Zhu, Tong; Jiang, Tongtong; Hu, Wenhao; Ma, Mingliang; Zhang, Xiongwen] East China Normal Univ, 更多

来源:ONCOTARGET,2016,7,48,79313-79327

收录类别:SCOPUS;SCIE;PubMed

当年影响因子:5.168

资源类型:外文期刊论文

6. NIR fluorescent DCPO glucose analogues and their application in cancer cell imaging 代表性成果 SCOPUS SCIE EI

作者:Chen, SG;Fang, YF;Zhu, QW;Zhang, WL;Zhang, XW;Lu, W

通讯作者:Zhang, Xiongwen

通讯作者地址:Lu, W (reprint author), East China Normal Univ, Sch Chem & Mol Engn, 3663 North Zhongshan Rd, Shanghai 200062, Peoples R China.; Lu, W (reprint author), Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116024, Peoples R China.

作者机构:[Chen, Shiguang; Fang, Yanfen; Zhu, Qiwen; Zhang, Wanli; Zhang, Xiongwen; Lu, Wei] East China Normal Univ, Sch Chem & Mol Engn, 3663 North Zhongshan R 更多

来源:RSC ADVANCES,2016,6,85,81894-81901

收录类别:SCOPUS;SCIE;EI

当年影响因子:3.108

WOS被引:2

Scopus被引:2

资源类型:外文期刊论文

8. Targeting NEK2 as a promising therapeutic approach for cancer treatment 代表性成果 SCOPUS SCIE PubMed

作者:Fang, YF;Zhang, XW

通讯作者地址:Zhang, XW (reprint author), Room B1505,Sci Bldg,3663 North Zhongshan Rd, Shanghai 200062, Peoples R China.

作者机构:[Fang, Yanfen; Zhang, Xiongwen] E China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Coll Chem & Mol Engn, Shanghai 200062, Peoples 更多

来源:CELL CYCLE,2016,15,7

收录类别:SCOPUS;SCIE;PubMed

当年影响因子:3.53

WOS被引:8

Scopus被引:8

资源类型:外文期刊论文

9. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides 代表性成果 SCIE

作者:Zhou, Z; Hu, TS; Xu, ZH; Lin, ZH; Zhang, ZS; Feng, T; Zhu, LC; Rong, YP; Shen, H; Luk, JM; Zhang, XW; Qin, N

通讯作者地址:Zhou, Z (reprint author), Roche Innovat Ctr Shanghai, Bldg 5,Lane 720,Cai Lun Rd, Shanghai 201203, Peoples R China.

作者机构:[Zhou, Zheng; Hu, Taishan; Xu, Zhiheng; Lin, Zhaohu; Zhang, Zhisen; Feng, Teng; Zhu, Liangcheng; Rong, Yiping; Shen, Hong; Luk, John M.; Zhang, Xiongw 更多

来源:FASEB JOURNAL,2015,29,2,724-732

收录类别:SCIE

当年影响因子:5.498

WOS被引:20

资源类型:外文期刊论文

13. Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors 代表性成果 SCIE

作者:Tang, GZ; Wong, JC; Zhang, WX; Wang, ZG; Zhang, N; Peng, ZH; Zhang, ZS; Rong, YP; Li, SJ; Zhang, MF; Yu, LJ; Feng, T; Zhang, XW; Wu, XH; Wu, JZ; Chen, L

通讯作者地址:Tang, GZ (reprint author), Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Shanghai, 720 Cailun Rd, Shanghai 201203, Peoples R China.

作者机构:[Tang, Guozhi; Wong, Jason C.; Zhang, Weixing; Wang, Zhanguo; Zhang, Nan; Peng, Zhenghong; Zhang, Zhenshan; Rong, Yiping; Li, Shijie; Zhang, Meifang; 更多

来源:JOURNAL OF MEDICINAL CHEMISTRY,2014,57,19,8026-8034

收录类别:SCIE

当年影响因子:6.259

WOS被引:12

资源类型:外文期刊论文

17. Pharmacokinetic Optimization of Class-Selective Histone Deacetylase Inhibitors and Identification of Associated Candidate Predictive Biomarkers of Hepatocellular Carcinoma Tumor Response 代表性成果 SCIE

作者:Wong, JC; Tang, GZ; Wu, XH; Liang, CG; Zhang, ZS; Guo, L; Peng, ZH; Zhang, WX; Lin, XF; Wang, ZG; Mei, JH; Chen, JL; Pan, S; Zhang, N; Liu, YF; Zhou, MW; Peng, LC; Zhao, WL; Li, SJ; Zhang, C; Zhang, MF; Rong, YP; Jin, TG; Zhang, XW; Ren, S; Ji, Y; Zhao, R; She, J; Ren, Y; Xu, CP; Chen, DW; Cai, J; Shan, S; Pan, DS; Ning, ZG; Lu, XP; Chen, TP; He, Y; Chen, L

通讯作者地址:Wong, JC (reprint author), 14 Moon Beam Dr, Mountain View, CA 94043 USA.

作者机构:[Wong, Jason C.; Tang, Guozhi; Wu, Xihan; Liang, Chungen; Zhang, Zhenshan; Guo, Lei; Peng, Zhenghong; Zhang, Weixing; Lin, Xianfeng; Wang, Zhanguo; Me 更多

来源:JOURNAL OF MEDICINAL CHEMISTRY,2012,55,20,8903-8925

收录类别:SCIE

当年影响因子:6.259

WOS被引:8

资源类型:外文期刊论文

共 4 页, 61 条记录

TOP